WGS · GeneDx Holdings Corp. · Documents

Jul 1

Current report 8-K Events of Jun 27

Director or officer change, or executive pay

Jun 14

Current report 8-K Events of Jun 10

Director or officer change, or executive pay, Regulation FD disclosure

May 12

Earnings call

Q1 2022 earnings call

May 12

Current report 8-K

Financial results

May 12

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $53.94M ▼ 16.0% Net loss $76.9M Diluted EPS -$0.31

May 3

Registration statement S-1

Registration statement

May 2

Current report 8-K Events of Apr 29

Entered into a material agreement, Completed an acquisition or sale of assets, Unregistered sale of equity, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Regulation FD disclosure, Other events

Apr 27

Current report 8-K

Shareholder vote results

Apr 18

Proxy statement DEFA14A

Proxy statement

Mar 31

Proxy statement DEFM14A

Proxy statement

Mar 15

Proxy statement PREM14A

Proxy statement

Mar 15

Proxy statement DEFA14A

Proxy statement

Mar 14

Current report 8-K Events of Mar 10

Financial results, Earlier financial statements no longer reliable

Mar 14

Earnings call

Q4 2021 earnings call

Mar 14

Current report 8-K Events of Mar 10

Financial results, Earlier financial statements no longer reliable

Mar 14

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $212.2M ▲ 18.3% Net loss $245.39M Diluted EPS -$2.27

Mar 14

Proxy statement DEFA14A

Proxy statement

Mar 8

Proxy statement DEFA14A

Proxy statement

Feb 22

Proxy statement DEFA14A

Proxy statement

Feb 17

Proxy statement DEFA14A

Proxy statement

Jan 31

Current report 8-K Events of Jan 25

Director or officer change, or executive pay

Jan 18

Current report 8-K Events of Jan 14

Entered into a material agreement, Unregistered sale of equity, Director or officer change, or executive pay, Regulation FD disclosure

Jan 18

Proxy statement DEFA14A

Proxy statement

Jan 18

Proxy statement DEFA14A

Proxy statement

Jan 10

Current report 8-K

Regulation FD disclosure

Jan 10

Current report 8-K

Regulation FD disclosure

Dec 16

Current report 8-K Events of Dec 15

Other events

Nov 15

Earnings call

Q3 2021 earnings call

Nov 15

Current report 8-K

Financial results

Nov 15

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $43.18M ▲ 11.8% Net income $31.39M Diluted EPS $0.15

Oct 14

Current report 8-K Events of Oct 8

Director or officer change, or executive pay

Aug 16

Earnings call

Q2 2021 earnings call

Aug 16

Current report 8-K/A Events of Jul 22

Completed an acquisition or sale of assets

Aug 16

Current report 8-K Events of Aug 13

Financial results, Change of auditor

Aug 4

Registration statement S-1

Registration statement

Jul 28

Current report 8-K Events of Jul 22

Entered into a material agreement, Completed an acquisition or sale of assets, Unregistered sale of equity, Change of auditor, Change in control, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Change in shell company status

Jul 22

Current report 8-K Events of Jul 21

Shareholder vote results

Jul 21

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Net income $13.01M

Jul 19

Current report 8-K

Other events

Jul 19

Proxy statement DEFA14A

Proxy statement

Jul 2

Proxy statement DEFM14A

Proxy statement

Jun 11

Proxy statement DEFA14A

Proxy statement

Jun 11

Proxy statement DEFA14A

Proxy statement

May 24

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Net loss $58.47M

May 18

Late filing notice NT 10-Q

Late filing notice

May 6

Proxy statement PREM14A

Proxy statement

May 5

Annual report 10-K/A Ended Dec 31

Annual report for the period ended Dec 31, 2020

May 5

Current report 8-K Events of May 3

Earlier financial statements no longer reliable

Mar 30

Annual report 10-K Ended Dec 31

Annual report for the period ended Dec 31, 2020

Feb 12

Proxy statement DEFA14A

Proxy statement